• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

    23.68 +2.80 (+13.41%)
    Streaming Delayed Price Updated: 3:08 PM EDT, Aug 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Zai Lab Limited - American Depositary Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    News headline image
    Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab Announces Participation in May and June Investor Conferences
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Recap: Zai Lab Q4 Earnings ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For February 27, 2024 ↗
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
    Via Benzinga
    News headline image
    Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA
    From Zai Lab Limited
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
     
    Via Benzinga
    News headline image
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
    Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
    Via InvestorPlace
    News headline image
    ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024 ↗
    ZLAB stock results show that Zai Lab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab Statement on Executive Management Team’s Agreement on Share Activities
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion ↗
    ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates... 
    Via Talk Markets
    News headline image
    Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs
    From Zai Lab Limited
    Via Business Wire
    News headline image
    One Good, One Bad News For Bristol Myers Squibb's Marketed Drugs: Details ↗
    Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint not met, safety consistent. Also, positive Phase 3 results for Krazati... 
    Via Benzinga
    News headline image
    Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Shhh! 7 Small-Cap Stocks That Can Double by 2025 ↗
    Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year. 
    Via InvestorPlace
    News headline image
    Stock Disconnect Triggers Investor Exodus From CStone Pharma ↗
    Key Takeaways: CEO Jason Yang has increased his CStone stake multiple times over the past 18 months to 4.79% of outstanding shares, signaling confidence in the company 
    Via Benzinga
    News headline image
    Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC)
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab Announces Participation in March Investor Conference
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
    From Zai Lab Limited
    Via Business Wire
    News headline image
    Top 5 Health Care Stocks That Are Preparing To Pump In February ↗
    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.